Press Releases

  • August 11, 2023

    Nemaura Medical Secures $6.5m in Non-Dilutive Funding

    Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on...

    July 14, 2023

    Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023

    Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    June 27, 2023

    Nemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023

    LOUGHBOROUGH, June 27, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    June 23, 2023

    Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023

    LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on...

    June 15, 2023

    Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023

    LOUGHBOROUGH, June 15, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    March 21, 2023

    Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton

    LOUGHBOROUGH, March 21, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    March 16, 2023

    Nemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License Agreement

    LOUGHBOROUGH, March 15, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    February 24, 2023

    Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update

    Loughborough, England, Feb. 24, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    February 16, 2023

    Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference

    Loughborough, England – February 16, 2023 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on...

    January 31, 2023

    Nemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

    LOUGHBOROUGH, Jan. 31, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...